Author Correction: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer.
Rahman R, Rahaman MH, Hanson AR, Choo N, Xie J, Townley SL, Shrestha R, Hassankhani R, Islam S, Ramm S, Simpson KJ, Risbridger GP, Best G, Centenera MM, Balk SP, Kichenadasse G, Taylor RA, Butler LM, Tilley WD, Conn SJ, Lawrence MG, Wang S, Selth LA.
Rahman R, et al. Among authors: wang s.
Br J Cancer. 2024 Nov;131(10):1719. doi: 10.1038/s41416-024-02862-w.
Br J Cancer. 2024.
PMID: 39448861
Free PMC article.
No abstract available.